Related Experiment Video
Updated: May 12, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
M-ds-P21 induces cell apoptosis in bladder cancer T24 cells through P53 independent pathway
Haifeng Wang1, Wujiang Liu, Jie Jin
1Department of Urology, Peking University First Hospital and Institute of Urology, Peking University, National Research Center for Genitourinary Oncology, Beijing, China.
Objectives:
To investigate the effect of M-ds-P21 on the apoptosis of bladder cancer T24 cells and its potential mechanism.
Materials And Methods:
Effect of M-ds-P21 on T24 cells were assessed by cell morphology and Western blot. Apoptosis was quantified by Annexin-V flow-cytometry analysis. To uncover the role of P53 in M-ds-P21-mediated apoptosis of T24 cells, we knocked down P53 before treating cells with M-ds-P21, and then assayed P21 and apoptosis-related protein by Western blot. To uncover the mechanism by which M-ds-P21 played stronger effect than ds-P21, we performed confocal microscope analyses.
Results:
Both M-ds-P21 and ds-P21 treatment changed the cell morphology, leading to cell apoptosis after 3 days. Apoptosis induced by M-ds-P21 and ds-P21 treatment is not P53-dependent but caspase-dependent. Compared with ds-P21, M-ds-P21 significantly increased the bioavailability of ds-RNA in T24 cells.
Conclusions:
M-ds-P21 treatment induces more apoptotic population than ds-P21 does. The mechanism for stronger effect of M-ds-P21 is partly due to the enhanced bioavailability of ds-RNA in human bladder cancer T24 cells, and not P53-dependent but caspase-dependent.
Insights
Modified double-stranded RNA (M-ds-P21) effectively induces apoptosis in bladder cancer cells. This enhanced effect is linked to increased ds-RNA bioavailability and caspase activation, independent of P53.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Bladder cancer remains a significant health concern, necessitating novel therapeutic strategies.
- Understanding the molecular mechanisms of apoptosis induction is crucial for developing effective cancer treatments.
Purpose of the Study:
- To evaluate the efficacy of M-ds-P21 in inducing apoptosis in T24 bladder cancer cells.
- To elucidate the underlying molecular mechanisms, including the role of P53 and caspase pathways.
Main Methods:
- T24 cells were treated with M-ds-P21 and ds-P21.
- Cell morphology, apoptosis (Annexin-V flow cytometry), and protein expression (Western blot) were analyzed.
- P53 knockdown was performed to assess its role in M-ds-P21-mediated apoptosis.
- Confocal microscopy was used to investigate the mechanism of enhanced M-ds-P21 activity.
Main Results:
- Both M-ds-P21 and ds-P21 induced apoptosis in T24 cells.
- M-ds-P21 demonstrated a significantly stronger apoptotic effect compared to ds-P21.
- Apoptosis was confirmed to be caspase-dependent and P53-independent.
- Enhanced bioavailability of ds-RNA in T24 cells was observed with M-ds-P21 treatment.
Conclusions:
- M-ds-P21 is a potent inducer of apoptosis in bladder cancer cells.
- The enhanced efficacy of M-ds-P21 is attributed to increased ds-RNA bioavailability.
- The apoptotic pathway activated by M-ds-P21 is caspase-dependent and does not involve P53.
Related Concept Videos
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
